Oxford BioDynamics Plc

$0.20+3.16%(+$0.01)
TickerSpark Score
54/100
Mixed
67
Valuation
20
Profitability
100
Growth
52
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OBD.L research report →

52-Week Range4% of range
Low $0.17
Current $0.20
High $0.78

Companywww.oxfordbiodynamics.com

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery.

CEO
Iain Gladstone Ross
IPO
2016
Employees
51
HQ
Oxford, GB

Price Chart

-39.69% · this period
$0.60$0.39$0.18May 23Nov 19May 21

Valuation

Market Cap
$4.18M
P/E
-0.20
P/S
3.81
P/B
1.97
EV/EBITDA
-0.81
Div Yield
0.00%

Profitability

Gross Margin
-561.55%
Op Margin
-973.79%
Net Margin
-1018.54%
ROE
-316.67%
ROIC
-153.84%

Growth & Income

Revenue
$1.09M · 72.17%
Net Income
$-11,153,000 · 3.58%
EPS
$-0.01 · 82.30%
Op Income
$-10,663,000
FCF YoY
28.24%

Performance & Tape

52W High
$0.78
52W Low
$0.17
50D MA
$0.21
200D MA
$0.31
Beta
-0.19
Avg Volume
10.06M

Get TickerSpark's AI analysis on OBD.L

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our OBD.L Coverage

We haven't published any research on OBD.L yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate OBD.L Report →

Similar Companies